tirzepatide alzheimer clinical trial Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies Tirzepatide Alzheimer's Research: Current Evidence
Description
Tirzepatide may cause fatigue through several mechanisms including reduced caloric intake from decreased appetite, slower gastric emptying, gastrointestinal side effects leading to dehydration, and the body's adjustment to normalized blood glucose levels
When Should You Escalate Beyond Home Care
The exact timeline for noticeable weight loss may differ, but most patients experience significant weight loss as they continue their treatment plan
The injections have no such timing rules
Its a GLP-1 (glucagon-like peptide-1) receptor agonist that regulates appetite and glucose levels, promoting weight loss as a secondary benefit
No hype
